B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment ...

There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition. While ...

Alemtuzumab is not a first-line therapy for MS. It is intended for people who have tried more than two other MS medications without relief from their symptoms or slowing of the progression of the ...

Summary of Infused DMTs DMT How It's Taken Common Side Effects Lemtrada (alemtuzumab) Infused for five days in a row for the first treatment course and then for three days in a row about one year ...

Aging is associated with a progressive decline of innate and adaptive immune responses, called immunosenescence. This phenomenon links to different multiple sclerosis (MS) disease courses among ...

This mini review summarizes the immunobiology of myelodysplastic syndromes, specifically focusing on the interactions between immune cells, cytokines, and dysplastic cells within the tumor ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.